tiprankstipranks
Infinity Pharmaceuticals (INFIQ)
OTHER OTC:INFIQ
US Market

Infinity Pharmaceuticals (INFIQ) Financial Statements

932 Followers

Infinity Pharmaceuticals Financial Overview

Infinity Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.457; its P/E ratio is -0.03; Infinity Pharmaceuticals is scheduled to report earnings on March 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 583.00K$ 731.00K$ 543.00K$ 712.00K$ 686.00K
Gross Profit$ 583.00K$ 731.00K$ 543.00K$ 283.00K$ 272.00K
EBIT$ -9.91M$ -11.00M$ -9.19M$ -10.67M$ -11.94M
EBITDA$ -9.80M$ -10.89M$ -9.08M$ -10.56M$ -11.82M
Net Income Common Stockholders$ -9.96M$ -11.04M$ -9.23M$ -10.72M$ -11.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 17.70M$ 25.70M$ 38.30M$ 47.18M$ 56.58M
Total Assets$ 21.19M$ 29.95M$ 42.15M$ 51.59M$ 61.86M
Total Debt$ 0.00$ 164.00K$ 324.00K$ 1.05M$ 1.19M
Net Debt$ -17.70M$ -25.54M$ -37.98M$ -46.13M$ -55.39M
Total Liabilities$ 58.64M$ 58.27M$ 61.20M$ 62.47M$ 62.96M
Stockholders Equity$ -37.45M$ -28.32M$ -19.05M$ -10.87M$ -1.11M
Cash Flow-
Free Cash Flow$ -8.01M$ 158.00K-$ -9.40M$ -10.60M
Operating Cash Flow$ -8.01M$ 158.00K-$ -9.40M$ -10.60M
Investing Cash Flow---$ 10.73M$ 3.28M
Financing Cash Flow$ 16.00K--$ 14.00K$ 28.00K
Currency in USD

Infinity Pharmaceuticals Earnings and Revenue History

Infinity Pharmaceuticals Debt to Assets

Infinity Pharmaceuticals Cash Flow

Infinity Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis